Skip to content

ASTEX PHARMACEUTICALS, INC

CIK 0000919722

← back to feed
Revenue (TTM)
$75.78M
+24.3% YoY Q2 Aug 2013
Net Income (TTM)
—
Q2 Aug 2013
EPS Diluted (TTM)
−$0.04
+350.0% YoY Q2 Aug 2013
Gross Margin
—
Q2 Aug 2013
Operating Margin
-24.7%
Q2 Aug 2013
Net Margin
—
Q2 Aug 2013
Free Cash Flow (TTM)
—
Q2 Aug 2013
Cash
$35.64M
Q2 Aug 2013
Total Debt
—
Q2 Aug 2013
Shares Outstanding
94.94M sh
Q2 Aug 2013

Revenue & Net Income

EPS (Diluted)

Margins

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings